Turn Therapeutics Inc.
Price Action
Technical Summary
WEAKENINGTurn Therapeutics Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 42), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (112% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.56 | +6.49% | ABOVE |
| 50 SMA | $3.49 | +8.47% | ABOVE |
| 100 SMA | $3.70 | +2.37% | ABOVE |
| 150 SMA | $— | — | |
| 200 SMA | $— | — |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TTRX in an uptrend right now?
TTRX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is TTRX overbought or oversold?
TTRX's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is TTRX outperforming the market?
TTRX has a Relative Strength (RS) Rating of 42 out of 99. TTRX is currently lagging the broader market.
Where is TTRX in its 52-week range?
TTRX is trading at $3.79, which is 14% of its 52-week high ($26.50) and 5% above its 52-week low ($2.57).
How volatile is TTRX?
TTRX has a Beta of 1.45 and 52-week volatility of 112%. It's more volatile than the S&P 500 - expect bigger swings.